DRIO DarioHealth Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: DRIO

Price (delayed)

$1.57

Market cap

$46.22M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.93

Enterprise value

$38.97M

DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software ...

Highlights
DRIO's EPS is up by 24% year-on-year and by 5% since the previous quarter
The quick ratio has decreased by 46% QoQ but it has increased by 13% YoY
The company's net income rose by 4.4% YoY but it fell by 2.9% QoQ
DarioHealth's gross profit has decreased by 38% YoY and by 30% from the previous quarter
DRIO's equity is down by 27% year-on-year and by 15% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.mydario.com
Peers: QURE CSBR

Key stats

What are the main financial stats of DRIO
Market
Shares outstanding
29.44M
Market cap
$46.22M
Enterprise value
$38.97M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.73
Price to sales (P/S)
2.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.91
Earnings
Revenue
$20.35M
EBIT
-$59.36M
EBITDA
-$54.38M
Free cash flow
-$30.96M
Per share
EPS
-$1.93
Free cash flow per share
-$1.09
Book value per share
$2.14
Revenue per share
$0.72
TBVPS
$1.74
Balance sheet
Total assets
$96.39M
Total liabilities
$38.25M
Debt
$29.54M
Equity
$58.14M
Working capital
$34.84M
Liquidity
Debt to equity
0.51
Current ratio
3.79
Quick ratio
3.38
Net debt/EBITDA
0.13
Margins
EBITDA margin
-267.2%
Gross margin
29.4%
Net margin
-292%
Operating margin
-276.1%
Efficiency
Return on assets
-59.3%
Return on equity
-91.8%
Return on invested capital
-181.7%
Return on capital employed
-70.8%
Return on sales
-291.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DRIO stock price

How has the DarioHealth stock price performed over time
Intraday
4.67%
1 week
6.08%
1 month
9.79%
1 year
-55.27%
YTD
-8.72%
QTD
2.61%

Financial performance

How have DarioHealth's revenue and profit performed over time
Revenue
$20.35M
Gross profit
$5.98M
Operating income
-$56.19M
Net income
-$59.43M
Gross margin
29.4%
Net margin
-292%
DarioHealth's gross profit has decreased by 38% YoY and by 30% from the previous quarter
DRIO's operating margin is down by 34% year-on-year and by 28% since the previous quarter
The net margin has contracted by 30% YoY and by 19% from the previous quarter
The revenue has declined by 26% year-on-year and by 14% since the previous quarter

Growth

What is DarioHealth's growth rate over time

Valuation

What is DarioHealth stock price valuation
P/E
N/A
P/B
0.73
P/S
2.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.91
DRIO's EPS is up by 24% year-on-year and by 5% since the previous quarter
The P/B is 64% lower than the 5-year quarterly average of 2.0 and 39% lower than the last 4 quarters average of 1.2
DRIO's equity is down by 27% year-on-year and by 15% since the previous quarter
DRIO's P/S is 73% below its 5-year quarterly average of 8.0 and 41% below its last 4 quarters average of 3.7
The revenue has declined by 26% year-on-year and by 14% since the previous quarter

Efficiency

How efficient is DarioHealth business performance
DarioHealth's return on equity has decreased by 38% YoY and by 13% QoQ
The ROIC has grown by 36% YoY
DRIO's ROS is down by 30% year-on-year and by 19% since the previous quarter
DRIO's ROA is down by 19% YoY and by 10% QoQ

Dividends

What is DRIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DRIO.

Financial health

How did DarioHealth financials performed over time
The total assets is 152% greater than the total liabilities
The quick ratio has decreased by 46% QoQ but it has increased by 13% YoY
DarioHealth's current ratio has decreased by 45% from the previous quarter but it has increased by 12% YoY
The debt is 49% less than the equity
The company's debt to equity rose by 46% YoY and by 16% QoQ
DRIO's equity is down by 27% year-on-year and by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.